Vnitr Lek 2024, 70(2):131-137 | DOI: 10.36290/vnl.2024.026
What´s new in Infectology?
- Klinika infekčních chorob Lékařské fakulty MU Brno a FN Brno
Infectious diseases are still a major health, social and economic problem in the 21st century. New treatment options for HIV and viral hepatitis D, the increasing incidence of viral hepatitis E and alveococcosis in the Czech Republic are discussed. In all cases, these are highly topical issues that are important in the Czech Republic and internationally. Long-acting slow effective release antiretroviral therapy (LASER ART) represents the most advanced form of modification of antiretroviral therapy (ART). It has been available in the Czech Republic since February 2023. According to clinical trials, 90-98 % of patients prefer a long-term regimen. Bulevirtide (BLV) is a synthetic lipopeptide, consisting of 47 amino acids from the preS1 domain of the large HBsAg protein, which binds to a specific receptor (sodium taurocholate cotransporting polypeptide - NTCP) on the surface of liver cells, thereby preventing HDV from entering the hepatocyte. BLV is the first approved antiviral drug for the treatment of hepatitis D in patients with compensated liver disease. The number of reported cases of acute hepatitis E in the Czech Republic from 2016-2021 was mostly around 200-250 cases per year. There will be an increase to 319 cases of acute hepatitis E in 2022 and even 684 cases in 2023. What is causing this is not yet definitively determined, but it is very likely that this increase is related to the increased prevalence of HEV infection in reservoir animals. Alveolar echinococcosis is caused by tapeworm Echinococcus multilocularis sensu lato. In Europe, foxes are the most common definitive host and rodents (mice, voles, etc.) are intermediate hosts. Transmission of infection occurs by ingestion of eggs contained in the faeces of definitive hosts: berries, mushrooms, wild garlic and other foods contaminated with the faeces of infected foxes. Clinically, the disease manifests itself as an invasive hepatic process similar in growth and spread to a malignant tumour, including the possibility of metastatic dissemination to other organs.
Keywords: HIV infection, AIDS, LASER ART, hepatitis D, bulevirtide, hepatitis E, alveolar echinococcosis, alveococcosis.
Accepted: March 26, 2024; Published: April 10, 2024 Show citation
References
- Dominick L, Midgley N, Swart LM, et al. HIV-related cardiovascular diseases: the search for a unifying hypothesis. Am J Physiol Heart Circ Physiol. 2020;318:H731-H746.
Go to original source...
Go to PubMed...
- Perkins MV, Joseph SB, Dittmer DP, et al. Cardiovascular disease and thrombosis in HIV infection. Arterioscler Thromb Vasc Biol. 2023;43:175-191.
Go to original source...
Go to PubMed...
- DHHS
- Srinivasa S, Thomas TS, Feldpausch MN, et al. Coronary vasculature and myocardial structure in HIV: physiologic insights from the renin-angiotensin-aldosterone system. J Clin Endocrinol Metab. 2021;106(12):3398-3412.
Go to original source...
Go to PubMed...
- Teer E, Dominick L, Mukonowenzou NC, et al. HIV-related myocardial fibrosis: inflammatory hypothesis and crucial role of immune cells dysregulation. Cells. 2022;11:2825. Available from: https://doi.org/10.3390/cells11182825.
Go to original source...
Go to PubMed...
- Werbel WA, Durand CM. Solid organ transplantation in HIV-infected recipients: history, progress, and frontiers. Curr HIV/AIDS Rep. 2019;16(3):191-203.
Go to original source...
Go to PubMed...
- Botha J, Fabian J, Etheredge H, et al. HIV and solid organ transplantation: where are we now. Curr HIV/AIDS Rep. 2019;16(5):404-413.
Go to original source...
Go to PubMed...
- Durand CM, Florman S, Motter JD, et al. HOPE in action: a prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV. Am J Transplant. 2022;22(3):853-864.
Go to original source...
Go to PubMed...
- Montero N, Moreso F, Cruzado JM. HIV-positive deceased donor-to-HIV-positive recipient kidney transplantation: The HOPE must go on. Am J Transplant. 2021;21(5):1683-1684.
Go to original source...
Go to PubMed...
- Durand CM, Zhang W, Brown DM, et al. A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action. Am J Transplant. 2021;21(5):1754-1764.
Go to original source...
Go to PubMed...
- Lushniak S, Durand CM. Donors with human immunodeficiency virus and hepatitis C virus for solid organ transplantation: what's new. Curr Opin Infect Dis. 2022;35(4):321-329.
Go to original source...
Go to PubMed...
- Klitenic SB, Levan ML, Van Pilsum Rasmussen SE, et al. Science over stigma: lessons and future direction of HIV-to-HIV transplantation. Curr Transpl Rep. 2021;8:314-323.
Go to original source...
Go to PubMed...
- Botha J, Conradie F, Etheredge H, et al. Living donor liver transplant from an HIV-positive mother to her HIV-negative child opening up new therapeutic options. AIDS. 2028;32(16):F13-F19.
Go to original source...
Go to PubMed...
- Thoueille P, Choong E, Cavassini M, Buclin T, Decosterd LA.J Antimicrob Chemother. 2022 Feb 2;77(2):290-302. doi: 10.1093/jac/dkab324.
Go to original source...
- Patil V, Patel A. Biodegradable nanoparticles: a recent approach and applications. Current Drug Targets. 2020; 21(16):1722-32.
Go to original source...
Go to PubMed...
- Kevadiya BD, Ottemann B, Mukadam IZ, et al. Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues. Theranostics. 2020;10(2):630-56.
Go to original source...
Go to PubMed...
- Soriano V, Fernandez-Montero JV, Benitez-Gutierrez L, Mendoza C, Arias A, Barreiro P, Peña JM, Labarga P. Dual antiretroviral therapy for HIV infection. Expert Opin Drug Saf. 2017 Aug;16(8):923-932
Go to original source...
Go to PubMed...
- Cutrell AG, Schapiro JM, Perno CF, Kuritzkes DR, Quercia R, Patel P, Polli JW, Dorey D, Wang Y, Wu S, Van Eygen V, Crauwels H, Ford SL, Baker M, Talarico CL, Clair MS, Jeffrey J, White CT, Vanveggel S, Vandermeulen K, Margolis DA, Aboud M, Spreen WR, van Lunzen J. Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis. AIDS. 2021 Jul 15;35(9):1333-1342. doi: 10.1097/QAD.0000000000002883.
Go to original source...
Go to PubMed...
- Overton ET, Richmond G, Rizzardini G, Thalme A, Girard PM, Wong A, Porteiro N, Swindells S, Reynes J, Noe S, Harrington C, Español CM, Acuipil C, Aksar A, Wang Y, Ford SL, Crauwels H, van Eygen V, Van Solingen-Ristea R, Latham CL, Thiagarajah S, D'Amico R, Smith KY, Vandermeulen K, Spreen WR. Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study. Clin Infect Dis. 2023 May 3;76(9):1646-1654. doi: 10.1093/cid/ciad020.
Go to original source...
Go to PubMed...
- Nachega JB, Scarsi KK, Gandhi M, Scott RK, Mofenson LM, Archary M, Nachman S, Decloedt E, Geng EH, Wilson L, Rawat A, Mellors JW. Long-acting antiretrovirals and HIV treatment adherence. Lancet HIV. 2023 May;10(5):e332-e342. doi: 10.1016/S2352-3018(23)00051-6.
Go to original source...
Go to PubMed...
- Brunetto MR, et al. EASL Clinical Practice Guidelines on hepatitis delta virus. J. Hepatol 2023;79:433-460.
Go to original source...
Go to PubMed...
- Husa P, Šperl J, Urbánek P, Fraňková S, Dlouhý P. Doporučený postup diagnostiky a léčby chronické hepatitidy D. Datum vydání doporučení. 2023. Vnitř Lék 2023;69(8):525-532.
Go to original source...
- Mihalčin M, Husa P. Vývoj poznatků o nemoci způsobené virem hepatitidy E. Vnitř Lék 2019;65(9):564-569.
Go to original source...
- Brunetti E, Kern P, Vuitton DA. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114(1):1-16. doi:10.1016/j.actatropica.2009.11.001
Go to original source...
Go to PubMed...
- CDC. CDC - DPDx - Echinococcosis. Published July 12, 2019. Accessed October 10, 2023. https://www.cdc.gov/dpdx/echinococcosis/index.html
- ECDC. The European Union One Health 2021 Zoonoses Report. Accessed October 10, 2023. https://www.ecdc.europa.eu/en/publications-data/european-union-one-health-2021-zoonoses-report
- WHO. Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis. Bull World Health Organ. 1996;74(3):231-242.